Fundraising Fox

Mori Arkin

Investor

Founder & Chairman at Arkin Capital

Israel

Writes $5K – $50K checks Β· typically $25K

About

Mori Arkin took over Agis, the pharmaceutical company founded by his father, and grew it into a global business in topical generics and active pharmaceutical ingredients before it was sold to Perrigo in 2005. He founded Arkin in 2009 as an investment platform focused on life sciences, including pharmaceuticals, biotechnology, and medical devices, and continues to advise the firm and take an active role in its life sciences investments. He holds an undergraduate degree in Psychology from Tel Aviv University and has published research on Renaissance art.

ContactΒ· published on Mori's own website

Invests in

BiotechHealthtechMedical Devices

Experience

  1. arkin holdingsChairmancurrent2008 β€” present
  2. arkin holdingsChairmancurrent2008 β€” presentIsrael

Investments

Board seats

OdysightSol-Gel TechnologiesVirility Medical

Per the firm's website.

Colleagues at Arkin Capital

Frequently asked questions

Who is Mori Arkin?
Mori Arkin took over Agis, the pharmaceutical company founded by his father, and grew it into a global business in topical generics and active pharmaceutical ingredients before it was sold to Perrigo in 2005. He founded Arkin in 2009 as an investment platform focused on life sciences, including pharmaceuticals, biotechnology, and medical devices, and continues to advise the firm and take an active role in its life sciences investments. He holds an undergraduate degree in Psychology from Tel Aviv University and has published research on Renaissance art.
Where does Mori Arkin work?
Mori Arkin is Founder & Chairman at Arkin Capital.
What does Mori Arkin invest in?
Mori Arkin invests in Biotech, Healthtech, Medical Devices.
What check size does Mori Arkin write?
Mori Arkin typically writes checks of $5K – $50K.
What boards does Mori Arkin sit on?
Mori Arkin holds tracked board seats at Odysight, Sol-Gel Technologies, Virility Medical.